- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06110832
The Effect of Mindfulness-based Yoga and Meditation on Some Parameters in Breast Cancer Patients
The Effect of Mindfulness-based Yoga and Meditation Practices on Stress, Self-esteem, Body Image and Sexual Adjustment in Breast Cancer Patients Undergoing Modified Radical Mastectomy: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study was conducted in a single-center, prospective (pretest-posttest-2. month follow-up), two-arm (1:1), randomized controlled experimental design.
In this study, the effects of an 8-week structured mindfulness-based meditation and yoga program on stress, self-esteem, body image and sexual adjustment will be evaluated in women undergoing modified radical mastectomy. The 8-week interventions were conducted by the researcher. The researcher who performed these applications has a certificate of mindfulness meditation, yoga, breathing and movement trainer. Due to the nature of the research, the researcher is involved in the implementation of the mindfulness-based meditation and yoga program, data collection and data entry into the system. At the same time, the women in the experimental group had to be informed about the research. Therefore, researcher and participant blinding could not be performed. However, randomization was performed to prevent selection bias (1:1). The randomization process was performed by a statistical expert other than the researcher and communicated to the researcher. The participants included in the study were numbered from 1 to 41, preserving their random order in the list received from the hospital. The groups were divided into Group 1 and Group 2 by the statistician and the first group was determined as the experimental group and the second group as the control group by lottery method. The randomization table was created by making use of "http://calculatorsoup.com". Before the 8-week process started, 3 measurements were made to the participants: pre-test, post-test at the end of 8 weeks and follow-up measurement 2 months after the application.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kütahya, Turkey
- Kutahya Health Science University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Able to read and write Turkish,
- Who have undergone modified radical mastectomy surgery,
- Female patients between the ages of 30-55,
- Premenopausal patients,
- At least 3 months have passed since the mastectomy operation and all available treatments (chemotherapy and/or radiotherapy treatments),
- No condition that constitutes an obstacle for active sexual life (for sexual compatibility assessment),
- Those who have not undergone plastic and reconstructive surgery for the breast after modified radical mastectomy,
- Those who have no previous meditation and/or yoga experience,
- Those who do not have a diagnosis of a mental disorder of organic origin,
- Those who do not have substance and/or alcohol addiction,
- Those who do not have severe depression accompanying the disease,
- Those who do not have a physical disability that would prevent participation in the study,
- Those who agree to participate in the study will be included in the sample.
Exclusion Criteria:
- Patients who received neoadjuvant chemotherapy in the preoperative period,
- Patients under the age of 30 and over the age of 55,
- Patients who have undergone oncoplastic, breast-conserving surgery,
- Patients with previous experience of mindfulness, meditation or yoga will not be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness-based Meditation and Yoga Intervention Group
After randomization, participants in the experimental group underwent mindfulness-based meditation and yoga practices with 90-minute sessions on Thursdays for 8 weeks. In these practices, a different theme was determined each week. The 8-week theme headings are as follows: Week 1 exploring mindfulness Week 2: How do we perceive the world? week 3 being in the body Week 4 meeting stress with mindful awareness Week 5 our relationship with stress-inducing thoughts Week 6 Communication with mindfulness Week 7 taking care of yourself Week 8 farewell and a new beginning |
In the mindfulness-based meditation and yoga program, mindfulness-based formal and informal interventions are conducted for 8 weeks.
|
|
No Intervention: Control Group
No intervention was applied to the control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale
Time Frame: Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
The Perceived Stress Scale developed by Cohen, Kamarck and Mermelstein (1983) consists of 14 items and has 2 sub-dimensions (perception of inadequate self-efficacy and perception of stress/discomfort).
Individuals are asked to rate on a 5-point Likert scale how often they have experienced certain feelings or thoughts in the last month.
|
Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rosenberg Self-Esteem Scale
Time Frame: Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
Rosenberg Self-Esteem Scale is a self-report scale consisting of 63 multiple-choice questions.
The scale consists of twelve subcategories.
Rosenberg stated that the subscales can be used separately in research if desired.
For the purpose of the study, the first '10' items of the scale will be used to measure self-esteem.
|
Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
|
Sexual Compliance and Body Image Scale
Time Frame: Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
The scale was developed by Dalton et al. to assess body image and sexuality in postoperative women with breast cancer.
It consists of two separate scales, the Body Image Scale and the Sexual Adjustment Scale.
The six-item Body Image Scale has two subscales, namely before body image score and after body image score.
These subscales measure body image before and after breast cancer diagnosis.
The eight-item Sexual Adjustment Scale has three subscales: sexual adjustment, sexual functioning and sexual importance of breasts score.
|
Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
|
Female Sexual Function Scale
Time Frame: Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
It is a personal tool for measuring sexual function that has been validated in women who have been clinically diagnosed with female sexual dysfunction.
The Female Sexual Function Scale was developed by Rosen et al. in the USA in 2000 as a 19-item multidimensional scale to assess female sexual function.
|
Week 1 (pre-test), Week 8 (final test) and 2nd month (follow-up measurement)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Melike Pehlivan, Kutahya Health Science University
- Study Director: Semra Eyi, Osmangazi University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KHSU-GSHMYO-MP-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Mindfulness-based Meditation and Yoga program
-
University of Wisconsin, MadisonThe Dana FoundationTerminated
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedGynecologic Cancer | Breast CancersUnited States
-
The Hong Kong Polytechnic UniversityRecruiting
-
Istanbul Aydın UniversityCompletedDomestic ViolenceTurkey
-
University of Alabama at BirminghamWithdrawnStress, Psychological
-
University Hospital, ToursNot yet recruitingChronic Kidney Disease Requiring HemodialysisFrance
-
Ebru DurusoyActive, not recruiting
-
Icahn School of Medicine at Mount SinaiNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Federal University of São PauloCompletedStress | Compassion | Anxiety